Alnylam Pharmaceuticals
ALNY
#802
Rank
โ‚ฌ27.73 B
Marketcap
207,28ย โ‚ฌ
Share price
1.51%
Change (1 day)
-45.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company